Santa Ana Bio Funding: $168M Raised, Series B (2024)
Santa Ana Bio has raised $168M in total funding. Latest round: Series B. Backed by Versant Ventures, GV.
Santa Ana Bio funding overview
Santa Ana Bio has raised $168M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in June 2024. The round record for Santa Ana Bio runs through 2024; nothing later has been disclosed. Investors on record include Versant Ventures, GV. 2 distinct backers are named across the disclosed rounds.
Santa Ana Bio at a glance
Total raised
$168M
Latest round
Series B
Latest round date
June 2024
Notable investors
Versant Ventures, GV
Frequently asked about Santa Ana Bio funding
How much has Santa Ana Bio raised?
Santa Ana Bio has raised $168M in total disclosed funding across the rounds on record.
Who has invested in Santa Ana Bio?
Versant Ventures, GV are named among the investors backing Santa Ana Bio.
What was the latest Santa Ana Bio funding round?
The most recent disclosed round is a Series B, announced in June 2024.
Where is Santa Ana Bio based?
No headquarters location is disclosed for Santa Ana Bio.
When did Santa Ana Bio last raise?
The last disclosed Santa Ana Bio round closed in June 2024 at Series B.
Totals shown for Santa Ana Bio aggregate every disclosed round on file. To see how that compares, browse the companies and the investors behind them below.
